Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sigma-Tau HealthScience is a specialized healthcare company focused on the development and distribution of evidence-based nutraceuticals and dietary supplements. Formerly a division of the Italian pharmaceutical giant Sigma-Tau, the company became part of the Alfasigma Group following a major merger in 2015. The company is a global leader in carnitine-based research, applying this expertise to address metabolic and reproductive health challenges. Its flagship product line, Proxeed, is a standard-of-care supplement used worldwide to support male and female fertility. Headquartered in Utrecht, Netherlands, Sigma-Tau HealthScience bridges the gap between pharmaceutical rigor and nutritional support through extensive clinical documentation of its products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sigma-Tau HealthScience.